Stopping aspirin after one month for heart attack patients
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether it is safe to stop taking aspirin after one month of dual blood thinner therapy (aspirin plus clopidogrel) in people who received stents for a heart attack or unstable angina. If you have been stable for a month with no bleeding or new heart events, this study explores whether just one blood thinner (clopidogrel alone) can be enough while lowering bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart attack or very unstable chest pain and got stents to open blocked arteries.
- All the important blockages were fixed during one procedure, and your blood flow was restored completely.
- You took two blood thinners (like aspirin and clopidogrel) every day for one month without problems like bleeding or new heart issues.
- You are not taking a blood thinner for another reason (like atrial fibrillation or blood clots) and do not have any other condition that requires long-term blood thinners.
- You have no history of serious bleeding, brain hemorrhage, or bleeding disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether taking two blood thinners (aspirin and clopidogrel) helps people who have had a stent placed to open a long-term total blockage in a heart artery. If you had a successful procedure to open such a blockage and are able to take aspirin, this trial might be for you.
This trial tests if a shorter, lower dose of two blood thinners is safe and effective for patients with a recent heart attack or unstable angina who are at high risk for bleeding. It uses a special stent that might allow for less medication.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests if people who have been on two blood thinners (aspirin plus prasugrel or ticagrelor) for at least 90 days after getting a heart stent can safely switch to just one of those blood thinners. It aims to see if taking only one pill is as safe and effective as taking two.
This trial tests whether taking just one month of two blood thinners after coronary artery bypass graft (CABG) surgery is safe and as effective as the standard longer course. It focuses on people having their first bypass surgery who receive at least one vein graft from the leg.
This study compares two ways to manage blood thinners after a stent. It tests whether switching from stronger drugs (prasugrel or ticagrelor) to clopidogrel is safe and effective for long-term heart protection.
Hear when a new Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.